InsiderTradesSIGMA

InsidersTradesSigma

← Executives ★ Sign in to follow

AP

Altman Peter

Chairman & CEO

C-suiteF

BioCardia, Inc.

Cumul. flow

0

Total declarations

0

Company

€319,005

▲ Purchases (64 ops.)

—

▼ Sales (0 ops.)

Insider track record

CEO

Disclosed buys

64

Disclosed sells

0

T+90 hit rate

38%

T+90 mean return

-12.5%

Across 24 buy signals with a settled T+90 return. Return basis: close on the day after publication.

Signal history

Browse the full record of transactions filed by Altman Peter, Chairman & CEO. Insider active across 1 company, notably BioCardia, Inc.. Cumulatively, 80 reports have been logged. Breakdown: 64 buys · 0 sell. Total volume traded: €319k. History available since 10 June 2021. The latest transaction was disclosed on 17 August 2026 (Acquisition). Regulator: SEC (Form 4). All data is free.

Companies and markets linked to Altman Peter

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

BioCardia, Inc. (US)

Declarations80 total

▲

President and CEOExecutives17 Aug 2026BioCardia, Inc.

$5,0220SEC ↗

5,400 shares@ US$0.93Common StockSEC:0001437749-26-028307:0

Canonical exit: 15 Nov 2026 (T+90)

▲

President and CEOExecutives13 Aug 2026BioCardia, Inc.

$1,74836SEC ↗

1,900 shares@ US$0.920.013% mcap0.1% of flowCommon StockSEC:0001437749-26-027743:0

Canonical exit: 11 Nov 2026 (T+90)

▲

President and CEOExecutives29 Jul 2026BioCardia, Inc.

$3,90038SEC ↗

5,000 shares@ US$0.780.033% mcap0.3% of flowCommon StockSEC:0001437749-26-024925:0

Canonical exit: 27 Oct 2026 (T+90)

▲

President and CEOExecutives17 Jul 2026BioCardia, Inc.

500 shares@ US$0.830.0034% mcap0.0% of flowCommon StockSEC:0001437749-26-023868:0

Canonical exit: 15 Oct 2026 (T+90)

▲

President and CEOExecutives14 Jul 2026BioCardia, Inc.

$2,46435SEC ↗

2,800 shares@ US$0.880.021% mcap0.2% of flowCommon StockSEC:0001437749-26-023637:0

Canonical exit: 12 Oct 2026 (T+90)

▲

President and CEOExecutives15 Jul 2026BioCardia, Inc.

$1,29033SEC ↗

1,500 shares@ US$0.860.011% mcap0.1% of flowCommon StockSEC:0001437749-26-023637:1

Canonical exit: 13 Oct 2026 (T+90)

▲

President and CEOExecutives9 Jul 2026BioCardia, Inc.

1,000 shares@ US$0.900.0068% mcap0.1% of flowCommon StockSEC:0001437749-26-023365:1

Canonical exit: 7 Oct 2026 (T+90)

▲

President and CEOExecutives8 Jul 2026BioCardia, Inc.

$5,33536SEC ↗

5,500 shares@ US$0.970.040% mcap0.4% of flowCommon StockSEC:0001437749-26-023365:0

Canonical exit: 6 Oct 2026 (T+90)

▲

President and CEOExecutives10 Jul 2026BioCardia, Inc.

1,000 shares@ US$0.940.0071% mcap0.1% of flowCommon StockSEC:0001437749-26-023365:2

Canonical exit: 8 Oct 2026 (T+90)

▲

President and CEOExecutives8 Jul 2026BioCardia, Inc.

$5,20836SEC ↗

5,400 shares@ US$0.96450.035% mcap0.5% of flowCommon StockSEC:0001437749-26-023016:0

Canonical exit: 6 Oct 2026 (T+90)

●

President and CEOExecutives2 Jul 2026BioCardia, Inc.

$67,71140SEC ↗

54,606 shares@ US$1.240.38% mcap6.0% of flowCommon StockSEC:0001437749-26-022969:0

◆

President and CEOExecutives29 Jun 2026BioCardia, Inc.

110,625 sharesCommon StockSEC:0001437749-26-022365:0

▲

President and CEOExecutives17 Jun 2026BioCardia, Inc.

1,500 sharesCommon StockSEC:0001437749-26-021216:0

Canonical exit: 15 Sept 2026 (T+90)

▲

President and CEOExecutives18 Jun 2026BioCardia, Inc.

800 sharesCommon StockSEC:0001437749-26-021216:1

Canonical exit: 16 Sept 2026 (T+90)

▲

President and CEOExecutives9 Jun 2026BioCardia, Inc.

5,000 sharesCommon StockSEC:0001437749-26-020044:0

Canonical exit: 7 Sept 2026 (T+90)

▲

President and CEOExecutives19 May 2026BioCardia, Inc.

200 shares@ US$0.950.0015% mcap0.0% of flowCommon StockSEC:0001437749-26-018125:0

Canonical exit: 17 Aug 2026 (T+90)

▲

President and CEOExecutives20 May 2026BioCardia, Inc.

$1,38044SEC ↗

1,500 shares@ US$0.920.011% mcap0.1% of flowCommon StockSEC:0001437749-26-018125:1

Canonical exit: 18 Aug 2026 (T+90)

▲

President and CEOExecutives15 May 2026BioCardia, Inc.

$5,20230SEC ↗

5,100 shares@ US$1.020.040% mcap2.5% of flowCommon StockSEC:0001437749-26-017459:0

Canonical exit: 13 Aug 2026 (T+90)

▲

President and CEOExecutives29 Apr 2026BioCardia, Inc.

$5,55033SEC ↗

5,000 shares@ US$1.110.030% mcap0.5% of flowCommon StockSEC:0001437749-26-013944:0

Canonical exit: 28 Jul 2026 (T+90)

▲

President and CEOExecutives20 Apr 2026BioCardia, Inc.

600 shares@ US$1.230.0047% mcap0.1% of flowCommon StockSEC:0001437749-26-013052:0

Canonical exit: 19 Jul 2026 (T+90)

▲

President and CEOExecutives21 Apr 2026BioCardia, Inc.

400 shares@ US$1.230.0032% mcap0.0% of flowCommon StockSEC:0001437749-26-013052:1

Canonical exit: 20 Jul 2026 (T+90)

▲

President and CEOExecutives24 Mar 2026BioCardia, Inc.

600 shares@ US$1.240.1% of flowCommon StockSEC:0001437749-26-009986:0

Canonical exit: 22 Jun 2026 (T+90)

▲

President and CEOExecutives4 Feb 2026BioCardia, Inc.

$5,65026SEC ↗

5,000 shares@ US$1.130.4% of flowCommon StockSEC:0001437749-26-003027:0

Canonical exit: 5 May 2026 (T+90)

▲

President and CEOExecutives20 Jan 2026BioCardia, Inc.

600 shares@ US$1.320.1% of flowCommon StockSEC:0001437749-26-001643:0

Canonical exit: 20 Apr 2026 (T+90)

▲

President and CEOExecutives16 Dec 2025BioCardia, Inc.

200 shares@ US$1.370.0% of flowCommon StockSEC:0001437749-25-038200:0

Canonical exit: 16 Mar 2026 (T+90)

25 of 80 declarations

About Altman Peter

Altman Peter is Président-Directeur Général and President and CEO of BioCardia, Inc. on XNAS. He has 74 filings in total, and across the 74 sampled filings the transactions are all acquisitions, with buy volume of EUR 306076 and no reported sell volume, between 2021-06-11 and 2026-07-10.